Informed consent: how much and what do patients understand?
Matthew E Falagas, Ioanna P Korbila, Konstantina P Giannopoulou...
https://pubmed.ncbi.nlm.nih.gov/19716887/Actively Recruiting
Led by Uludag University · Updated on 2026-08-25
75
Participants Needed
1
Research Sites
N/A
Total Duration
This observational study aims to explore whether a participants understanding of the informed consent information affects the amount of propofol needed during endobronchial ultrasound EBUS. EBUS is a minimally invasive procedure using a thin camera and ultrasound to examine lymph nodes and other areas inside the chest. Sedation is commonly used during EBUS to improve comfort and tolerance, and this study investigates the link between consent understanding and sedation needs without changing routine care. Participants scheduled for elective EBUS will undergo the usual informed consent process, after which their understanding will be assessed with a structured questionnaire. Anxiety levels before the procedure will also be measured. During EBUS, participants will receive standard sedation and monitoring, with no intervention from the study. The research team will record propofol use, additional sedation needs, clinical events during sedation, and early recovery characteristics. Participants will complete assessments about their consent understanding and anxiety before the procedure. Sedative medication use, need for extra sedation, clinical events, and recovery within 15 to 30 minutes after EBUS will be recorded. The study will analyze whether better consent understanding is linked to lower propofol use while considering clinical factors. The total participation includes assessments before, during, and shortly after the procedure, with all care following routine clinical practice.
CONDITIONS
Consent Understanding and Propofol Requirement During Endobronchial Ultrasound
G
Gokce Kizilkale Kayikci, MD
L
Leman Gokcenur Aydin, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uludag University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - On the day of the procedure
Participants complete questions about their understanding of the consent information and their anxiety level before the endobronchial ultrasound procedure.
1 visit (in-person)
Duration - Duration of the procedure
Participants undergo the endobronchial ultrasound with usual sedation and monitoring. Sedative medication use, additional sedation needs, clinical events, and recovery are recorded.
During procedure monitoring
Duration - 30 minutes after procedure
Participants are observed for early recovery characteristics and patient satisfaction after sedation, with assessments at 15 and 30 minutes post-procedure.
2 follow-up assessments
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Matthew E Falagas, Ioanna P Korbila, Konstantina P Giannopoulou...
https://pubmed.ncbi.nlm.nih.gov/19716887/Peter Grendelmeier, Gabriel Kurer, Eric Pflimlin...
https://pubmed.ncbi.nlm.nih.gov/21870301/Roberto F Casal, Donald R Lazarus, Kristine Kuhl...
https://pubmed.ncbi.nlm.nih.gov/25574801/Funda Çetinkaya, Esin Kavuran, Kevser Sevgi Ünal Aslan
https://pubmed.ncbi.nlm.nih.gov/30764595/Momen M Wahidi, Felix Herth, Kazuhiro Yasufuku...
https://pubmed.ncbi.nlm.nih.gov/26402427/N Moerman, F S van Dam, M J Muller...
https://pubmed.ncbi.nlm.nih.gov/8623940/Uludag University
Lead Sponsor